{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:01:36Z","timestamp":1790424096009,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.cca.2015.08.009","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T05:46:50Z","timestamp":1439531210000},"page":"162-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Leptin in Alzheimer's disease"],"prefix":"10.1016","volume":"450","author":[{"given":"Magalh\u00e3es","family":"CA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carvalho","family":"MG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sousa","family":"LP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caramelli","family":"P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gomes","family":"KB","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2015.08.009_bb0005","author":"Alzheimer\u2019s association"},{"key":"10.1016\/j.cca.2015.08.009_bb0010","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1017\/S1041610209009430","article-title":"Prevalence of dementia in Latin America: a collaborative study of population-based cohorts","volume":"21","author":"Nitrini","year":"2009","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.cca.2015.08.009_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S1516-44462005000100017","article-title":"Decline of cognitive capacity during aging","volume":"27","author":"Charchat-Fichman","year":"2005","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.cca.2015.08.009_bb0020","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1093\/brain\/awl280","article-title":"Therapeutic approaches to Alzheimer\u2019s disease","volume":"129","author":"Klafki","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.cca.2015.08.009_bb0025","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1590\/S0004-282X2005000400034","article-title":"Diagnosis of Alzheimer's disease in Brazil: cognitive and functional evaluation. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology","volume":"63","author":"Nitrini","year":"2005","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.cca.2015.08.009_bb0030","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1590\/S0004-282X2004000500001","article-title":"Hyperphosphorylated tau protein in the cerebrospinal fluid of patients with Alzheimer's disease and other dementias: preliminary findings","volume":"62","author":"Hartmann","year":"2004","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.cca.2015.08.009_bb0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cca.2015.08.009_bb0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1590\/0004-282X20130233","article-title":"Biological markers of Alzheimer's disease","volume":"72","author":"Souza","year":"2014","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.cca.2015.08.009_bb0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cca.2013.04.013","article-title":"High cortisol levels are associated with cognitive impairment no-dementia (CIND) and dementia","volume":"423","author":"Lara","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2015.08.009_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pneurobio.2014.07.004","article-title":"Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum","volume":"121","author":"R\u00edos","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.cca.2015.08.009_bb0055","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1212\/01.wnl.0000343499.72241.ea","article-title":"Central obesity and increased risk of dementia more than three decades later","volume":"72","author":"Tezapsidis","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.08.009_bb0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1467-789X.2008.00473.x","article-title":"Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis","volume":"9","author":"Beydoun","year":"2008","journal-title":"Obes. Rev."},{"key":"10.1016\/j.cca.2015.08.009_bb0065","first-page":"1330","article-title":"Obesity in middle age and future risk of dementia: a 27year longitudinal population based study","author":"Whitmer","year":"2005","journal-title":"Br. Med. J."},{"key":"10.1016\/j.cca.2015.08.009_bb0070","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.euroneuro.2014.03.002","article-title":"Obesity and dementia: Adipokines interact with the brain","volume":"24","author":"Arnoldussen","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.cca.2015.08.009_bb0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1567205010666131120110930","article-title":"Change in Body Mass Index Before and After Alzheimer\u2019s Disease Onset","volume":"11","author":"Gu","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cca.2015.08.009_bb0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(14)70085-7","article-title":"Adipokines: a link between obesity and dementia?","volume":"13","author":"Kiliaan","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2015.08.009_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/156720507780362074","article-title":"An introduction to obesity and dementia","volume":"4","author":"Barrett-connor","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cca.2015.08.009_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jns.2010.08.036","article-title":"Adiposity hormones and dementia","volume":"29","author":"Gustafson","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2015.08.009_bb0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jalz.2011.05.2411","article-title":"Leptin and dementia over 32years -The Prospective Population Study of Women","volume":"8","author":"Gustafson","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cca.2015.08.009_bb0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/gerona\/gls155","article-title":"Leptin, mild cognitive impairment, and dementia among elderly women","volume":"68","author":"Zeki","year":"2013","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.cca.2015.08.009_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2014.04.028","article-title":"Immunohistochemical analysis of tau phosphorylation and astroglial activation with enhanced leptin receptor expression in diet-induced obesity mouse hippocampus","volume":"571","author":"Koga","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cca.2015.08.009_bb0110","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/01.wnl.0000176061.33817.90","article-title":"Change in body mass index and risk of incident Alzheimer disease","volume":"65","author":"Buchman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.08.009_bb0115","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10545-005-0038-5","article-title":"Phenotypic heterogeneity in biochemical parameters correlates with mutations in AGPAT2 or Seipin genes among Berardinelli-Seip congenital lipodystrophy patients","volume":"28","author":"Gomes","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2015.08.009_bb0120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cca.2015.08.009_bb0125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(97)06348-4","article-title":"Leptin","volume":"351","author":"Auwerx","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2015.08.009_bb0130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jnc.12380","article-title":"Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance","volume":"128","author":"Bonda","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2015.08.009_bb0135","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1126\/science.7624778","article-title":"Recombinant mouse OB protein; evidence for a peripheral signal linking adiposity and central neural networks","volume":"269","author":"Campfield","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.cca.2015.08.009_bb0140","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.ijo.0802142","article-title":"Leptin: a review of its peripheral actions and interactions","volume":"26","author":"Margetic","year":"2002","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.cca.2015.08.009_bb0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JAD-2011-110266","article-title":"TNF and leptin tell essentially the same story in Alzheimer's disease","volume":"26","author":"Clark","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cca.2015.08.009_bb0150","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1357-2725(98)00094-6","article-title":"Leptin","volume":"30","author":"Prolo","year":"1998","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cca.2015.08.009_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2011.06274.x","article-title":"Obesity, leptin, and Alzheimer's disease","volume":"1243","author":"Lee","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2015.08.009_bb0160","first-page":"245","article-title":"Leptin signaling and Alzheimer\u2019s disease","volume":"1","author":"Marwarha","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.cca.2015.08.009_bb0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/157488909789104848","article-title":"Therapeutic approaches of leptin in Alzheimer's disease","volume":"4","author":"Carro","year":"2009","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.cca.2015.08.009_bb0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/JME-12-0151","article-title":"Neuroprotective and anti-ageing role of leptin","volume":"49","author":"Folch","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.cca.2015.08.009_bb0175","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.2174\/13816128113199990612","article-title":"Metabolic basis of sporadic Alzeimer's disease. Role of hormones related to energy metabolism","volume":"19","author":"Folch","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cca.2015.08.009_bb0180","doi-asserted-by":"crossref","first-page":"e20286","DOI":"10.1371\/journal.pone.0020286","article-title":"Adipocytokines and CD34 progenitor cells in Alzheimer's disease","volume":"6","author":"Bigalke","year":"2011","journal-title":"PLos One"},{"key":"10.1016\/j.cca.2015.08.009_bb0185","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12603-012-0058-4","article-title":"Ghrelin and leptin secretion in patients with moderate Alzheimer's disease","volume":"16","author":"Theodoropoulou","year":"2012","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.cca.2015.08.009_bb0190","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.peptides.2005.10.006","article-title":"Effects of leptin on memory processing","volume":"27","author":"Farr","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.cca.2015.08.009_bb0195","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000339956","article-title":"Leptin and cognition","volume":"33","author":"Warren","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.cca.2015.08.009_bb0200","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.arr.2013.01.009","article-title":"Food for thought: the role of appetitive peptides in age-related cognitive decline","volume":"12","author":"Fadel","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cca.2015.08.009_bb0205","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1001\/jama.2009.1836","article-title":"Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging","volume":"302","author":"Lieb","year":"2009","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.cca.2015.08.009_bb0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/gerona\/gls155","article-title":"Leptin, mild cognitive impairment, and dementia among elderly women","volume":"68","author":"Hazzouri","year":"2013","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.cca.2015.08.009_bb0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WNR.0b013e32835c5254","article-title":"Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly","volume":"24","author":"Rajagopalan","year":"2013","journal-title":"Neuroreport"},{"key":"10.1016\/j.cca.2015.08.009_bb0220","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-140006","article-title":"Altered Serum Levels of Adipokines and Insulin in Probable Alzheimer's Disease","volume":"41","author":"Khemka","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cca.2015.08.009_bb0225","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/acel.12281","article-title":"Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer\u2019s disease","volume":"14","author":"Maioli","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.cca.2015.08.009_bb0230","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-141503","article-title":"Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease","volume":"44","author":"Teunissen","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cca.2015.08.009_bb0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ageing\/afu160","article-title":"Plasma leptin levels are not predictive of dementia in patients with mild cognitive impairment","volume":"44","author":"Oania","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.cca.2015.08.009_bb0240","first-page":"1870","article-title":"Obesity-related leptin regulates Alzheimer's Abeta","volume":"15","author":"Fewlass","year":"2004","journal-title":"J. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.cca.2015.08.009_bb0245","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3233\/JAD-2010-1308","article-title":"Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease","volume":"19","author":"Greco","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cca.2015.08.009_bb0250","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbrc.2011.09.050","article-title":"Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and beta-amyloid in neurons","volume":"414","author":"Greco","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2015.08.009_bb0255","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2009.01.041","article-title":"Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells","volume":"380","author":"Greco","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2015.08.009_bb0260","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bbrc.2008.09.026","article-title":"Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells","volume":"376","author":"Greco","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2015.08.009_bb0265","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.mcn.2007.05.001","article-title":"Leptin promotes rapid dynamic changes in hippocampal dendritic morphology","volume":"35","author":"O\u2019Malley","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.cca.2015.08.009_bb0270","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/JAD-2009-1021","article-title":"Leptin: a novel therapeutic strategy for Alzheimer's disease","volume":"16","author":"Tezapsidis","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cca.2015.08.009_bb0275","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbadis.2012.12.009","article-title":"Leptin regulates amyloid \u03b2 production via the \u03b3-secretase complex","volume":"1832","author":"Niedowicz","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2015.08.009_bb0280","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bbadis.2014.05.015","article-title":"Leptin attenuates BACE1 expression and amyloid-\u03b2 genesis via the activation of SIRT1 signaling pathway","volume":"1842","author":"Marwarha","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2015.08.009_bb0285","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0074-7742(07)82006-X","article-title":"New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection","volume":"82","author":"Turner","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.cca.2015.08.009_bb0290","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cca.2015.08.009_bb0295","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/jne.12138","article-title":"Protective Effect of Leptin and Ghrelin against Toxicity Induced by Amyloid-\u03b2 Oligomers in a Hypothalamic cell line","volume":"26","author":"Gomes","year":"2014","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.cca.2015.08.009_bb0300","first-page":"1348","article-title":"Amyloid oligomers: formation and toxicity of Abeta oligomers","volume":"277","author":"Sakono","year":"2010","journal-title":"Fed. Eur. Biochem. Soc. J."},{"key":"10.1016\/j.cca.2015.08.009_bb0305","first-page":"605","article-title":"Clearance of Alzheimer\u2019s Abeta peptide: the many roads to perdition","volume":"43","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.cca.2015.08.009_bb0310","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2013.04.016","article-title":"Ketamine reduces amyloid b-protein degradation by suppressing neprilysin expression in primary cultured astrocytes","volume":"545","author":"Yamamoto","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cca.2015.08.009_bb0315","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbrc.2014.01.168","article-title":"Leptin inhibits amyloid b-protein degradation through decrease of neprilysin expression in primary cultured astrocytes","volume":"445","author":"Yamamoto","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2015.08.009_bb0320","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/WAD.0b013e3181b982dc","article-title":"Lack of association between the leptin receptor gene (LEPR) Gln223Arg polymorphism and late-onset Alzheimer disease","volume":"24","author":"Utsunomiya","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.cca.2015.08.009_bb0325","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/gt.2013.85","article-title":"Leptin gene therapy attenuates neuronal damages evoked by amyloid-\u03b2 and rescues memory deficits in APP\/PS1 mice","volume":"21","author":"P\u00e9rez-Gonz\u00e1lez","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.cca.2015.08.009_bb0330","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1742-1241.2010.02536.x","article-title":"The procognitive effects of leptin in the brain and their clinical implications","volume":"64","author":"Paz-filho","year":"2010","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.cca.2015.08.009_bb0335","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1567205010666131212114156","article-title":"Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential","volume":"11","author":"Johnston","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cca.2015.08.009_bb0340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2013.02.062","article-title":"Protective Leptin and Ghrelin prevent hippocampal dysfunction induced by A\u03b2 oligomers","volume":"241","author":"Martins","year":"2013","journal-title":"Neuroscience"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115003800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115003800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T10:33:20Z","timestamp":1567074800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898115003800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":68,"alternative-id":["S0009898115003800"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2015.08.009","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leptin in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2015.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}